Login / Signup

Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis.

Klaus SchmiererHeinz WiendlCelia Oreja-GuevaraDiego CentonzeAnita ChudeckaSanjeev RoyUrsula Boschert
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • white matter
  • peritoneal dialysis
  • mass spectrometry
  • ms ms
  • patient reported outcomes